磷酸胆碱通过RAB27A激酶上调外泌体释放hsa_circ_0054903干预NOTCH信号通路促进子宫内膜癌间质上皮转化的机制研究
批准号:
82072859
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
石琨
依托单位:
学科分类:
肿瘤复发与转移
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
石琨
中文摘要
间质上皮转化MET与子宫内膜癌EC侵袭转移密切相关。前期代谢组学发现磷酸胆碱PCho在患者血清中表达显著升高并促进MET。为阐明其机制,进行全转录组测序,显示PCho处理组EC细胞hsa_circ_0054903、NOTCH阻遏分子CIR1、RAB27A表达上调,hsa-miR-301b-3p表达下调,进一步研究发现RAB27A过表达EC细胞上清液中外泌体表达hsa_circ_0054903、CIR1及MET分子上调。据此提出科学假说:PCho上调RAB27A促进外泌体释放hsa_circ_0054903通过干预hsa-miR-301b-3p抑制NOTCH信号通路从而促进EC MET。为验证该假说,拟在临床样本中验证以上各分子及NOTCH调控、效应分子的表达,利用体内外实验探讨PCho通过RAB27A调控外泌体介导RNA海绵调控促进EC MET机制,以期为EC靶向治疗提供新的理论依据。
英文摘要
It is reported mesenchymal-epithelial transition (MET) promotes proliferation of endometrial carcinoma (EC). Our previous metabolomics study revealed that expression of phosphocholine (PCho) significantly increased in serum of EC patients and was associated with MET. Competing endogenous RNA sequencing showed that the expressions of hsa_circ_0054903, CIR1mRNA and RAB27AmRNA in EC cells cultured with PCho were significantly up-regulated, while the expression of hsa-mir-301b-3p was down-regulated. Subsequently, it was shown that the expression of hsa_circ_0054903 in the exosome, as well as the transcription of CIR1 and MET biomarker were also up-regulated in RAB27Aoverexpressed EC cells. Based on previous studies and the pilot data, a scientific hypothesis was proposed: PCho stimulated hsa_circ_0054903 secretion from exosomes by upregulation of RAB27A and this intervened the effect of hsa-mir-301b-3p and thereby might inhibit NOTCH signaling pathway, which then promoted MET ofEC. In order to verify the hypothesis, we plan first to verify the expressions of RAB27A, hsa_circ_0054903, hsa-mir-301b-3p and the regulators and the effectors in NOTCH signaling pathway in clinical samples, and then further investigate the mechanism of EC MET in vivo and in vitro that stimulated by PCho, which was mediated by RNA sponge regulation network through RAB27A-stimulated exosome secretion,to provide a novel rationale for EC treatment.
妇科恶性肿瘤细胞中存在异常的代谢进程。细胞内代谢产物的积累往往可导致基因组改变,从而引发一系列生物学特性改变。前期发现磷酸胆碱(Phosphocholine,PCho)在子宫内膜癌(Endometrial cancer,EC)肿瘤组织中上调。本项目研究PCho抑制癌细胞的迁移和侵袭,同时促进间质-上皮转化的机制,发现PCho可上调外泌体中两种环状RNA(hsa_circ_0002967和hsa_circ_0018767)的表达,与hsa-miR-548g-5p相互作用,从而上调其靶基因RAB27A激酶表达,进而抑制Notch信号通路的活性。揭示了PCho通过外泌体携带的环状RNA影响肿瘤细胞的转化和迁移的潜在机制,为子宫内膜癌的治疗提供了新的靶点(拟投稿)。进一步挖掘分子机制,我们发现在EC肿瘤组织中,PCho与原癌基因MYC表达负相关,PCho可通过抑制c-Myc蛋白表达损害EC细胞的增殖能力和干性。PCho的积累可促进EC细胞内过量活性氧的产生,并显著下调了GTPase HRAS 的表达,导致EC细胞内mTOR-c-Myc轴的抑制,进而损害EC细胞的增殖能力并诱导其凋亡(Cellular and Molecular Life Sciences,2024)。此外,我们还研究EC患者异常表达代谢产物吲哚丙烯酸(Indoleacrylic Acid, IAA),发现IAA来源于阴道菌群失调,并通过IL-10/IFN-γ途径参与IDO1诱导和免疫耐受,同时验证了M2巨噬细胞是IAA刺激后IL-10生成的主要来源。该研究揭示了EC患者生殖道中的子宫共生消化性链球菌群失调与IAA、IDO1诱导免疫耐受之间的联系(Biomedicines,2024)。另外,我们还研究了含锌指SWIM结构域蛋白4(ZSWIM4)对上皮性卵巢癌(Epithelial ovarian cancer, EOC)细胞化疗抵抗的作用及机制,发现ZSWIM4抑制通过改善细胞内甘氨酸代谢重编程增强EOC细胞的化疗敏感性(Journal of Translational Medicine,2024)。我们还发现小分子抑制剂CBR-5884通过靶向抑制ITGB4/ERK/EMT信号轴抑制EOC细胞的迁移和侵袭,并增强化疗敏感性(Discover Oncology,2024)。
国内基金
海外基金